Colonoscopy Screening and Polyp Detection in the Southeastern United States

Abstract

Cancer is the second leading cause of death in the United States (U.S.) (Centers for Disease Control and Prevention, 2017). according to Siegel, Miller, and jemal (2019), it is estimated that over 1.7 million people will be diagnosed with cancer and, of those diagnosed, over 600,000 will die from the disease. The National Cancer Institute (2019) estimates that between 3% and 35% of cancer-related deaths could be prevented by screening. Screening may also decrease morbidity rates, as it is often easier to treat an early-stage cancer as opposed to a late-stage cancer. BackgroundColorectal cancer (CRC) is the third cause of cancerrelated deaths (excluding certain skin cancers), and is the third most common cancer in both men and women (Centers for Disease Control and Prevention, 2020). There are an estimated 240,000 new cases diagnosed each year with approximately 112,000 deaths. arnold et al. ( 2017) estimate that the incidence rate for CRC will increase by 60% by the year 2030.advances in screening and treatment of CRC in the U.S. have resulted in decreased mortality rates (Hunleth, Steinmetz, McQueen, & james, 2016). Screening for CRC allows for detection and removal of precancerous polyps, which are directly linked to a decline in incidence rates (Lieberman et al., 2016). furthermore, according to the american Cancer Society (aCS, 2020), screening and early detection leads to an increase in survivability among CRC

Virtual colonoscopy and fibrocolonoscopy in colorectal polyp patients

“…Резултатите от скрининговите колоноскопии в Южните американски щати показват документация за колоректални полипи при 239 от 534-ма болни на средна възраст от 62 г. (при 44,76% от случаите) (10). Касае се за хиперпластични и аденоматозни полипи, като смесени типове се установяват при 16-20% от тази извадка от населението.…”